Prognostic impact of pretreatment immunoglobulin clonal composition in pediatric B-lymphoblastic leukemia

• Carol Fries,
• Lik Wee Lee,
• Meenakshi Devidas,
• Yunfeng Dai,
• Karen R. Rabin,
• Sumit Gupta,
• Mignon L. Loh,
• Ilan R Kirsch,
• Brent Wood,
• Rachel E. Rau

Affiliations

Carol Fries

Department of Pediatrics, Hematology/Oncology, University of Rochester, Rochester

Lik Wee Lee

Adaptive Biotechnologies, Inc., Seattle, WA

Meenakshi Devidas

Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis

Yunfeng Dai

Department of Biostatistics, College of Medicine and Public Health and Health Professions, University of Florida, Gainesville, FL

Karen R. Rabin

Department of Pediatrics, Texas Children’s Cancer Center, Baylor College of Medicine, Houston

Sumit Gupta

Division of Hematology/Oncology, Hospital for Sick Children, Faculty of Medicine, University of Toronto, Toronto, ON

Mignon L. Loh

Department of Pediatrics, Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, Seattle, WA

Ilan R Kirsch

Adaptive Biotechnologies, Inc., Seattle, WA

Brent Wood

Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA

Rachel E. Rau

Department of Pediatrics, Texas Children’s Cancer Center, Baylor College of Medicine, Houston